553 related articles for article (PubMed ID: 9443742)
1. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
3. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
5. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
6. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
[TBL] [Abstract][Full Text] [Related]
11. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions.
Liu L; Song Y; Gao S; Ji T; Zhang H; Ji B; Chen B; Jia B; Wang F; Xu Z; Ma Q
Mol Imaging; 2014; 13(5):. PubMed ID: 24825112
[TBL] [Abstract][Full Text] [Related]
12. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
Palmedo H; Biersack HJ; Lastoria S; Maublant J; Prats E; Stegner HE; Bourgeois P; Hustinx R; Hilson AJ; Bischof-Delaloye A
Eur J Nucl Med; 1998 Apr; 25(4):375-85. PubMed ID: 9553167
[TBL] [Abstract][Full Text] [Related]
13. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
14. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
Uriarte I; Carril JM; Quirce R; Gutiérrez-Mendiguchía C; Blanco I; Banzo I; Vega A; Hernández A
Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
[TBL] [Abstract][Full Text] [Related]
15. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
16. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
[TBL] [Abstract][Full Text] [Related]
18. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
[TBL] [Abstract][Full Text] [Related]
19. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
20. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
